Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: Relevance for differential diagnosis

This publication has 38 references indexed in Scilit:

• The value of preoperative serum CA 125 levels in patients with a pelvic mass
  American Journal of Obstetrics and Gynecology, 1988
• Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease
  American Journal of Obstetrics and Gynecology, 1988
• Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen
  American Journal of Obstetrics and Gynecology, 1984
• Detection of Malignant Ovarian Neoplasms
  Obstetrical & Gynecological Survey, 1984
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Antigenic determinants of human placental and testicular placental‐like alkaline phosphatases as mapped by monoclonal antibodies
  European Journal of Biochemistry, 1983
• Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125
  International Journal of Gynecological Pathology, 1983
• Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell Types
  American Journal of Clinical Pathology, 1983
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981
• Significance, Importance and Equality—Three Basic Concepts in the Analysis of a Difference
  Upsala Journal of Medical Sciences, 1980